De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Oblong Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Oblong heeft een totaal eigen vermogen van $5.1M en een totale schuld van $0.0, wat de schuld-eigenvermogensverhouding op 0% brengt. De totale activa en totale passiva bedragen respectievelijk $6.3M en $1.3M.

Belangrijke informatie

Verhouding schuld/eigen vermogen

US$0

Schuld

Rente dekkingsratio	n/a
Contant	US$5.86m
Aandelen	US$5.05m
Totaal verplichtingen	US$1.25m
Totaal activa	US$6.31m

Recente financiële gezondheidsupdates

Recent updates

Shareholders Are Thrilled That The Oblong (NASDAQ:OBLG) Share Price Increased 160%

Mar 15

Breakeven On The Horizon For Oblong Inc. (NYSEMKT:OBLG)

Feb 12

Have Insiders Been Selling Oblong Inc. (NYSEMKT:OBLG) Shares This Year?

Dec 21

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $6.3M ) OBLG } overtreffen de korte termijn passiva ( $1.2M ).

Langlopende schulden: De kortetermijnactiva OBLG ( $6.3M ) overtreffen de langetermijnschulden ( $6.0K ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: OBLG is schuldenvrij.

Schuld verminderen: OBLG had 5 jaar geleden geen schulden.

Balans

Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: OBLG heeft op basis van de huidige vrije kasstroom voldoende kasstroom voor meer dan een jaar.

Voorspelling contante baan: OBLG heeft voldoende kasruimte voor 1.6 jaar als de vrije kasstroom blijft groeien met een historisch percentage van 22.8 % per jaar.

Oblong Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Oblong Announces Compliance with Nasdaq Bid Price Requirement

Oblong Announces Reverse Stock Split to Satisfy the Nasdaq Capital Market’s Continued Listing Standards

Oblong Receives 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule

Oblong Receives Non-Compliance Notice From Nasdaq

Oblong Announces Compliance with Nasdaq Bid Price Requirement

Oblong Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule

Recent updates

Oblong Announces Compliance with Nasdaq Bid Price Requirement

Oblong Announces Reverse Stock Split to Satisfy the Nasdaq Capital Market’s Continued Listing Standards

Second quarter 2024 earnings released: US$0.044 loss per share (vs US$0.78 loss in 2Q 2023)

Dwellwell Analytics, Inc. entered into a letter of intent to acquire Oblong, Inc. (NasdaqCM:OBLG) in a reverse merger transaction on June 4, 2024.

Oblong, Inc. (NasdaqCM:OBLG) signed a non-binding letter of intent to acquire an unknown stake in Dwellwell Analytics, Inc.

First quarter 2024 earnings released: US$0.069 loss per share (vs US$0.60 loss in 1Q 2023)

Oblong Receives 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule

Full year 2023 earnings released: US$0.98 loss per share (vs US$10.63 loss in FY 2022)

Third quarter 2023 earnings released: US$0.30 loss per share (vs US$3.48 loss in 3Q 2022)

Oblong, Inc., Annual General Meeting, Dec 04, 2023

New major risk - Share price stability

Oblong Receives Non-Compliance Notice From Nasdaq

New major risk - Shareholder dilution

Second quarter 2023 earnings released: US$0.78 loss per share (vs US$4.40 loss in 2Q 2022)

Oblong, Inc. Announces Board Changes

First quarter 2023 earnings released: US$0.60 loss per share (vs US$2.21 loss in 1Q 2022)

Full year 2022 earnings released: US$10.63 loss per share (vs US$5.51 loss in FY 2021)

Oblong Announces Compliance with Nasdaq Bid Price Requirement

Oblong, Inc., Annual General Meeting, Dec 30, 2022

Third quarter 2022 earnings released: US$0.23 loss per share (vs US$0.022 loss in 3Q 2021)

Third quarter 2022 earnings released: US$232 loss per share (vs US$0.022 loss in 3Q 2021)

Oblong, Inc. to Report Q3, 2022 Results on Nov 10, 2022

Oblong Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule

Oblong gets 180-day extension to comply with Nasdaq's minimum bid price rule

Second quarter 2022 earnings released: US$0.29 loss per share (vs US$0.084 loss in 2Q 2021)

Oblong, Inc. to Report Q2, 2022 Results on Aug 09, 2022

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Oblong Inc. Reports Impairment Charges for the First Quarter Ended March 31, 2022

Oblong Inc. to Report Q1, 2022 Results on May 11, 2022

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Oblong Inc. Announces Termination of Pete Hawkes as Senior Vice President of Product, Design & Engineering

Third quarter 2021 earnings released: US$0.022 loss per share (vs US$0.40 loss in 3Q 2020)

Is Oblong (NASDAQ:OBLG) A Risky Investment?

High number of new and inexperienced directors

Second quarter 2021 earnings released: US$0.084 loss per share (vs US$0.65 loss in 2Q 2020)

Oblong Inc. Reports Impairment Charges for the Second Quarter Ended June 30, 2021

Oblong (NASDAQ:OBLG) Has Debt But No Earnings; Should You Worry?

Oblong to be a part of Russell Microcap Index

Forecast to breakeven in 2023

First quarter 2021 earnings released: US$0.23 loss per share (vs US$0.60 loss in 1Q 2020)

Is Oblong (NASDAQ:OBLG) A Risky Investment?

Full year 2020 earnings released: US$1.48 loss per share (vs US$1.53 loss in FY 2019)

Shareholders Are Thrilled That The Oblong (NASDAQ:OBLG) Share Price Increased 160%

New 90-day low: US$4.11

Breakeven On The Horizon For Oblong Inc. (NYSEMKT:OBLG)

Oblong, Inc. Announces New Cisco Webex Certification

Have Insiders Been Selling Oblong Inc. (NYSEMKT:OBLG) Shares This Year?

Insider recently sold US$411k worth of stock

New 90-day high: US$9.50

Oblong Inc., Annual General Meeting, Dec 22, 2020

Third quarter 2020 earnings released: US$0.40 loss per share

Oblong Inc. Announces Resignation of John Underkoffler as Director

New 90-day high: US$4.09

First half earnings released

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Analyse van de cashflow

Ontdek gezonde bedrijven